×
About 810 results

ALLMedicine™ Hydatidiform Mole Center

Research & Reviews  281 results

Changes in diagnostic sensitivity, incidence and presentation of complete and partial h...
https://doi.org/10.1016/j.ejogrb.2022.05.026
European Journal of Obstetrics, Gynecology, and Reproduct... Aiob A, Naskovica K et. al.

Jun 1st, 2022 - Molar pregnancy is the most common type of gestational trophoblastic disease. Several recent reports have described changes in the clinical representation, the incidence and the diagnostic sensitivity of molar pregnancy. These changes could be due...

Dietary Factors and Incidence of Hydatidiform Mole: An Ecological Study.
https://doi.org/10.1080/01635581.2022.2079688
Nutrition and Cancer; Wang X, Du Y et. al.

May 28th, 2022 - The current ecological study aims to explore the association between dietary factors and hydatidiform mole (HM) incidence in Japan and China. HM incidence in Japan gradually declined from 1970s to 1990s, while the dietary structure also changed du...

Partial Hydatidiform Mole with a Coexistent Twin Pregnancy: A Successful Outcome with E...
https://doi.org/10.1016/j.jogc.2021.01.017
Journal of Obstetrics and Gynaecology Canada : JOGC = Jou... Banerjee A, Oniah M et. al.

May 20th, 2022 - Partial Hydatidiform Mole with a Coexistent Twin Pregnancy: A Successful Outcome with Expectant Management.|2022|Banerjee A,Oniah M,Cohn MR,Marsden L,|

The Presence of the Autophagic Markers LC3B and Sequestosome 1/p62 in the Hydatidiform ...
https://doi.org/10.1097/PGP.0000000000000886
International Journal of Gynecological Pathology : Offici... Karpathiou G, Dridi M et. al.

May 6th, 2022 - Autophagy is implicated in normal pregnancy and various pathologic pregnancy conditions. Its presence in hydatidiform moles (HM) is unknown. We immunohistochemically studied 36 HM for LC3B and p62 to precisely determine their expression in the dec...

Study of the Genetic and Epigenetic Causes of Recurrent Hydatidiform Moles
https://clinicaltrials.gov/ct2/show/NCT01008501

Apr 25th, 2022 - Hydatidiform mole (HM) is the product of an aberrant human pregnancy in which there is abnormal embryonic development and abnormal proliferation of placental villi. The incidence of HM varies between ethnic groups, and occurs in 1 in every 1500 pr...

see more →

Guidelines  2 results

Directive clinique no 408 : Prise en charge des maladies gestationnelles trophoblastiques.
https://doi.org/10.1016/j.jogc.2020.10.008
Journal of Obstetrics and Gynaecology Canada : JOGC = Jou... Eiriksson L, Dean E et. al.

Jan 2nd, 2021 - Cette directive passe en revue l'évaluation clinique et la prise en charge des maladies gestationnelles trophoblastiques, notamment les traitements chirurgicaux et médicamenteux des tumeurs bénignes, prémalignes et malignes. L'objectif de la prése...

Gestational Trophoblastic Neoplasia, Version 2.2019, NCCN Clinical Practice Guidelines ...
https://doi.org/10.6004/jnccn.2019.0053
Journal of the National Comprehensive Cancer Network : JN... Abu-Rustum NR, Yashar CM et. al.

Nov 7th, 2019 - Gestational trophoblastic neoplasia (GTN), a subset of gestational trophoblastic disease (GTD), occurs when tumors develop in the cells that would normally form the placenta during pregnancy. The NCCN Guidelines for Gestational Trophoblastic Neopl...

see more →

Drugs  21 results see all →

Clinicaltrials.gov  12 results

Study of the Genetic and Epigenetic Causes of Recurrent Hydatidiform Moles
https://clinicaltrials.gov/ct2/show/NCT01008501

Apr 25th, 2022 - Hydatidiform mole (HM) is the product of an aberrant human pregnancy in which there is abnormal embryonic development and abnormal proliferation of placental villi. The incidence of HM varies between ethnic groups, and occurs in 1 in every 1500 pr...

Letrozole as a Prophylaxis From GTN for Complete Mole Patients
https://clinicaltrials.gov/ct2/show/NCT05203562

Feb 24th, 2022 - Management of hydatidiform mole is usually evacuation followed by β-hcg surveillance to early detect cases of GTN . The risk of developing GTN is reported to be 16% to 20% in women with CHM . GTN is a potentially life-threatening malignancy but ha...

Study of Different Therapeutic Strategies in Hydatidiform Mole With Lung Nodule
https://clinicaltrials.gov/ct2/show/NCT03785574

Oct 29th, 2021 - The hydatidiform mole patients with lung nodule ≥1.0cm will be randomized into 2 groups: A. treated with chemotherapy immediately, B. follow up until hCG level met FIGO diagnostic criteria of GTN (B1) or hCG level declined to normal spontaneously ...

Avelumab in Chemo-resistant Gestational Trophoblastic Neoplasias
https://clinicaltrials.gov/ct2/show/NCT03135769

Sep 2nd, 2021 - Gestational trophoblastic neoplasias (GTN) are characterized by the persistence of elevated hCG titers after complete uterine evacuation of a partial hydatidiform mole (PHM) or a complete hydatidiform mole. GTN patients are commonly treated with s...

Avelumab and Methotrexate in in Low-risk Gestational Trophoblastic Neoplasias as First Line Treatment
https://clinicaltrials.gov/ct2/show/NCT04396223

May 22nd, 2020 - Gestational trophoblastic neoplasias (GTN) are characterized by the persistence of elevated hCG titers after complete uterine evacuation of a partial hydatidiform mole (PHM) or a complete hydatidiform mole. Low-risk GTN patients (FIGO score ≤ 6) a...

see more →

News  7 results

First-ever gestational trophoblastic neoplasia guidelines published
https://www.mdedge.com/obgyn/article/172712/gynecologic-cancer/first-ever-gestational-trophoblastic-neoplasia-guidelines
Neil Osterweil

Aug 15th, 2018 - The National Comprehensive Cancer Network (NCCN) has issued its first-ever clinical practice guidelines for the treatment of gestational trophoblastic neoplasia (GTN), a rare, serious complication of pregnancy that can often be cured, but can have.

A woman with heavy noncyclical bleeding 6 weeks after abortion
https://www.mdedge.com/obgyn/article/138947/woman-heavy-noncyclical-bleeding-6-weeks-after-abortion
Devaraju Kanmaniraja, MD, Andrew M. Kaunitz, MD

May 25th, 2017 - A) Retained products of conception (RPOC) INCORRECT RPOC is a common complication arising from the presence of retained placental or fetal tissue after delivery, spontaneous, or elective abortion and is diagnosed by the presence of chorionic villi.

Diagnosis at a Glance: Partial Hydatidiform Molar Pregnancy
https://www.mdedge.com/emergencymedicine/article/129144/obstetrics/diagnosis-glance-partial-hydatidiform-molar-pregnancy
Marion-Vincent Mempin, MD, MSc, Poonam Desai, DO et. al.

Jan 11th, 2017 - Case A 26-year-old gravida 3, para 2-0-0-2, aborta 0 whose last menstrual period was 15 weeks 5 days, presented to the ED with complaints of mild vaginal spotting, which she first noted postcoitally the previous day. The patient denied fatigue, li.

Postpartum VTE Risk Highest Soon After Birth
https://www.medscape.com/viewarticle/823218

Apr 7th, 2014 - A woman's risk for postpartum venous thromboembolism (VTE) is highest in the first few weeks after delivery and then drops steadily through week 12, a new study suggests. Pregnancy complications increase the risk for postpartum VTE. The study is o...

Postpartum VTE Risk Highest Soon After Birth
https://www.staging.medscape.com/viewarticle/823218

Apr 7th, 2014 - A woman's risk for postpartum venous thromboembolism (VTE) is highest in the first few weeks after delivery and then drops steadily through week 12, a new study suggests. Pregnancy complications increase the risk for postpartum VTE. The study is o...

see more →

Patient Education  1 results see all →